Search

everythinglearnresearchcommunity

for

Search:↓

Portuguese WAA-QoL questionnaire validated; FPHL severity, schooling, and phototypes affect patients' quality of life.

COVID-19 can cause hair loss starting as early as 18 days after infection.

Low-dose oral minoxidil may cause side effects like hypertrichosis and is not suitable for everyone.

Minoxidil base is preferred for hair loss treatment, but minoxidil sulfate may be an alternative for unresponsive patients.

Minoxidil increases nail growth more than biotin.

Hair enzyme activity predicts minoxidil success in Brazilian women with hair loss.

Aryl hydrocarbon receptor overexpression found in miniaturized hair follicles in female hair loss.

Carboxytherapy did not significantly improve burn healing in rats.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

COVID-19 may cause early hair loss by infecting hair follicles.

The conclusion is that 24 weeks of low-dose oral minoxidil is safe for men with hair loss, with no significant changes in heart rate or blood pressure.

Female pattern hair loss affects 32.3% of women, increasing with age and showing no racial differences.

Tufted folliculitis is common in patients with folliculitis decalvans.

Certain genetic factors may contribute to frontal fibrosing alopecia in Brazil.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.

Only anti-androgenic drugs likely halt AGA progression.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Diagonal earlobe and preauricular creases may indicate higher coronary artery disease risk in men.

A new topical treatment using micelles shows promise for safer and more effective hair regrowth in androgenetic alopecia.

Both 2.5 mg and 5 mg doses of oral minoxidil are effective for hair regrowth in men with hair loss.

Bicalutamide may take longer to work for female hair loss, and higher doses might be needed.

The Brazilian version of the Alopecia Areata Quality of Life Index is reliable for assessing patients' quality of life.

Bicalutamide added no extra benefit over minoxidil alone for female-pattern hair loss.

Sublingual and oral minoxidil are equally effective for hair growth, but sublingual causes fewer palpitations.

Oral minoxidil boosts hair and nail growth speed.

Low-dose oral minoxidil is generally safe for hypertensive patients with hair loss.

Oral minoxidil 7.5 mg for hair loss increases heart rate but not blood pressure.

Using both minoxidil and biotin together increased hair growth more than using either one alone.